Tumor type and expression of markers in lung cancer cases. | Download Table
The 5 Tumor Markers You Must Know About Lung Cancer - Mindray Global
Clinical relevance of molecular markers in lung cancer - ScienceDirect
Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization - Journal of Thoracic Oncology
Clinical characteristics, CTC count, and tumor markers of lung cancer... | Download Table
![PDF] Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9f8e3ef5835b350425251c81aa92d6fd5751b05d/2-Table1-1.png "PDF] Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation | Semantic Scholar")
PDF] Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation | Semantic Scholar
Survival Prediction and Adjuvant Chemotherapy Based on Tumor Marker for Stage IB Lung Adenocarcinoma - The Annals of Thoracic Surgery
The 5 Tumor Markers You Must Know About Lung Cancer - Mindray Global
PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer
SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
Blood tumour markers warn against the progression of lung cancer
Clinical Utility of Tumor Markers
Frontiers | Targeting Lung Cancer Stem Cells: Research and Clinical Impacts
Small cell lung cancer tumor markers: Types, ranges, and more
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer | PLOS ONE
The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases - Journal of Thoracic Oncology
Lung Cancer Tumor Markers | GeneTex
Prognostic markers in lung cancer: is it ready for prime time? - Zhu - Translational Lung Cancer Research
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer | PLOS ONE
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer - Lung Cancer
Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - Lung Cancer
Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research
What are common tumor markers? - Quora
Prognostic Impact of Angiogenic Markers in Non–Small-Cell Lung Cancer is Related to Tumor Size - Clinical Lung Cancer
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. | Semantic Scholar
